Is Stoke Therapeutics, Inc. (STOK) a Buy, Sell, or Hold?
Stoke Therapeutics, Inc.
NASDAQ:STOK
$29.13 USD
-$0.33 (-1.12%)
- Volume
- 560.3K
- Average Volume
- 709.65K
- Market Capitalization
- $1.81B
- P/E Ratio
- -10.29
- Dividend Yield
- 0.00%
- Price Target
- $44.00
- Year High
- $40.22
- Year Low
- $11.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.99
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-33.8% DOWNSIDE
$44.00 Price Target
UPSIDE/DOWNSIDE HIGH
-51.5% DOWNSIDE
$60.00 Price Target High
UPSIDE/DOWNSIDE LOW
-27.2% DOWNSIDE
$40.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Goldman Sachs | Kevin Strang | $44 | $31.38 | 2026-07-13 05:25 AM | 40.2% |
| Guggenheim | Yatin Suneja | $60 | $32 | 2026-02-05 04:55 AM | 87.5% |
| Loop Capital Markets | Keay Nakae | $35 | $30.9 | 2026-01-05 04:23 AM | 13.3% |
| H.C. Wainwright | Andrew Fein | $50 | $32.9 | 2025-12-16 06:49 AM | 52.0% |